Dashboard: Filter Bricks
Main page content
Displaying results 1 - 6 of 6
Publication ID: PEP24-03-001
Published:
SAMHSA’s updated Overdose Prevention and Response Toolkit provides guidance to a wide range of individuals on preventing and responding to an overdose. The toolkit also emphasizes that harm reduction and access to treatment are essential aspects of overdose prevention.
Publication ID: PEP23-03-00-001
Published:
SAMHSA’s updated Overdose Prevention and Response Toolkit provides guidance to a wide range of individuals on preventing and responding to an overdose. The toolkit also emphasizes that harm reduction and access to treatment are essential aspects of overdose prevention.
Publication ID: PEP23-06-00-001
Published:
This advisory introduces readers to digital therapeutics (DTx) and the benefits of their use in behavioral health. It describes the research, regulatory, and reimbursement implications for DTx as well as selection and implementation considerations.
Publication ID: PEP21-02-01-003
Published:
The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
Publication ID: PEP21-02-01-002
Published:
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.
Publication ID: PEP20-03-01-002
Published:
A brochure for parents and caregivers about the risks associated with misusing prescription pain medications for teens and the importance of having conversations with their children to help them avoid taking medication that is not theirs.